Pathology

Steven A. Moore, MD, PhD

Portrait

Director of Neuropathology
Co-Director, Wellstone Muscular Dystrophy Cooperative Research Center
Professor of Pathology  - Anatomic and Clinical Pathology

Contact Information

Primary Office: 5239B Roy Carver Pavilion
Iowa City, IA 52242
Primary Office Phone: 319-384-9084

Lab: 4270A Carver Biomedical Research Building
Iowa City, IA 52242
Phone: 319-335-8215

Email: steven-moore@uiowa.edu
Web: Muscular Dystrophy Diagnostic Service
Web: Dr. Moore's Research Laboratory

Education

BS, Purdue University
PhD, Anatomy, Indiana University
MD, Indiana University School of Medicine

Residency, University of Iowa College of Medicine
Fellowship, University of Iowa College of Medicine

Licensure and Certifications

Anatomic Pathology, American Board of Pathology
Neuropathology, American Board of Pathology

Education/Training Program Affiliations

Biosciences Graduate Program
Department of Pathology Graduate Program
Interdisciplinary Graduate Program in Neuroscience

Research Summary

Muscular dystrophies are a diverse group of inherited disorders characterized by progressive muscle weakness and wasting. Dr. Moore is involved in the evaluation of patient biopsies and in research partially funded through a center grant from NIH. This Paul D. Wellstone Muscular Dystrophy Cooperative Research Center is exploring therapeutic strategies for the treatment of various muscular dystrophies by enabling translational research on muscular dystrophies and providing advanced diagnostic services. The MDCRC is composed of two research projects, three cores and investigators with a proven track record of excellence and collaboration. The Center researchers' studies and facilities will explore basic biological mechanisms that relate to possible treatments for muscular dystrophies, facilitate translational research on muscular dystrophies and provide advanced diagnostic services to patients and clinical trial participants. The Director and Co-director, Kevin Campbell and Steven Moore, are investigators with established records in basic, translational, and clinical research on muscular dystrophy.

Additional basic science collaboration with Dr. Kevin Campbell, Department of Molecular Physiology and Biophysics ( The Laboratory of Dr. Kevin P. Campbell) involves the pathologic characterization of genetic mouse models of muscular dystrophy. Many of these models use Cre-lox methodology to selectively knock out brain or peripheral nerve dystroglycan. These mice model congenital muscular dystrophy. A second basic science collaboration is with Lori Wallrath (Department of Biochemistry, The University of Iowa) studying lamin A/C.

Including the Wellstone MDCRC mentioned above, clinical diagnostic work in the general area of muscular dystophies has expanded into basic and clinical research projects in collaboration with several physicians at other institutions, Kevin Campbell, and Kathy Mathews (Department of Pediatrics, The University of Iowa). Current clinical studies involve: (1) a natural history study of patients with dystroglycanopathy, (2) a search for new genes in congenital myopathy and muscular dystrophy patients, (3) dysferlinopathy patients with amyloid deposition, (4) autophagic vacuolar myopathy patients, and (5) improvements in diagnostic testing.

Center, Program and Institute Affiliations

Center for Gene Therapy of Cystic Fibrosis and other Genetic Diseases
Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center

All Publications

Crockett C, Ruggieri A, Gujrati M, Zallek C, Ramachandran N, Minassian B, Moore S.  Late-adult onset of X-liked myopathy with excessive autophagy (XMEA).  Muscle Nerve;  2014. 

Goddeeris M, Wu B, Venzke D, Yoshida-Moriguchi T, Saito F, Matsumura K, Moore S, Campbell K.  LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy.  Nature.  2013 November 7. 503(7474):136-40.
[PubMed]

Khoo M, Hebbar S, Zhao W, Moore S, Oberley L, Domann F, Robbins M.  Differential Activation of catalase expression and activity by PPAR agonists: implications for astrocyte protection in anti-glioma therapy.  Redox Biology.  2013 January 26. 1(1):70-79.
[PubMed]

Moore S, Nguyen H, Lutz K, Bai Y, Shy M, Mathews K.  Brain and peripheral nerve pathology in merosin-deficient congenital muscular dystrophy: similarities to dystroglycanopathy.  J Neuropathol Exp Neurol.  2013. 72:584-585.

Moore S, Gujrati M, Zallek C, Ramachandran N, Minassian B.  Late-adult onset of X-linked myopathy with excess autophagy (XMEA).  J Neuropathol Exp Neurol.  2013. 72:586.

Carss K, Stevens E, Foley A, Cirak S, Riemersma M, Torelli S, Hoischen A, Willer T, van Scherpenzeel M, Moore S, Messina S, Bertini E, Bonnemann C, Abdenur J, Grosmann C, Kesari A, Punetha J, Quinlivan R, Waddell L, Young H, Wraige E, Yau S, Brodd L, Feng L, Sewry C, MacArthur D, North K, Hoffman E, Stemple D, Hurles M, van Bokhoven H, Campbell K, Lefeber D, Lin Y, Muntoni F.  Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan.  Am J Hum Genet.  2013. 93:1-13.
[PubMed]

Davidson A, Siddiqui F, Lopez M, Lunt P, Carlson H, Moore B, Love S, Roper H, Born D, Majumdar A, Jayadev S, Underhill H, Smith C, von der Hagen J, Hubner A, Jardine P, Merrison A, Curtis E, Cullup T, Jungbluth H, Cox M, Winder T, Abdel-Salam H, Li J, Moore S, Dowling J.  Novel deletion of lysine 7 expands the clinical, histopathologic and genetic spectrum of TPM2-related myopathies.  Brain.  2013. 136:508-521.
[PubMed]

Moore S, Kuinecka P, Swenson A, Deol R, Harris B, Lewis A, Vogel H, Hayashi Y, Nishino I, McAllister J, Pattee G, McComb R.  Siblings with a novel CHKB mutation are identified among clinically diverse patients with megaconial myopathy. .  J Neuropathol Exp Neurol.  2013. 72:545.

Cirak S, Foley A, Herrmann R, Willer T, Yau S, Stevens E, Torelli S, Brodd L, Kamynina A, Vondracek P, Roper H, Longman C, Korinthenberg R, Marrosu G, Nurnberg P,  , Michele D, Plagnol V, Hurles M, Moore S, Sewry C, Campbell K, Voit T, Muntoni F.  ISPD Gene Mutations are a common cause of congenital and limb-girdle muscular dystrophies.  Brain.  2013 January. 136(Pt 1):269-81.
[PubMed]

Chauveau C, Julien C, Marks H, Foley R, Kho A, Talim B, Arne-Bes M, Uro-Coste E, Maury P, Vihola A, Udd B, Topaloglu H, Moore S, Gautel M, Bonnemann C, Samuels M, Ferreiro A.  Tackling giants with next generation sequencing: Homozygous or compound heterozygous truncating mutations of TTN define novel forms of cardiomyopathy with skeletal myopathy.  American Society of Medical Genetics.  2012 November. 

Dowling J, Davidson A, Lopez M, Siddiqui F, Lung P, Li J, Jungbluth H, Love S, Moore S.  Expanding the clinical and genetic phenotype of TPM2-related myopathies.  World Muscle Society.  2012 October. 

Nguyen N, Satz J, Turk R, Campbell K, Moore S.  Neuronal alpha-dystroglycan is important for proper GABAA receptor-alpha1 clustering in Purkinje neurons.  Society for Neuroscience Meeting.  2012 October. 

Tesi Rocha C, Taylor M, Chang T, Reyes C, Winder T, Moore S, Bonnemann C, Nelson K.  Novel homozygous stop mutation in alphaB crystalline: expanding the phenotype.  World Muscle Society.  2012 October. 

Willer T, Lee H, Lommel M, Yoshida-Moriguchi T, Beltran Valero de Bernabe D, Venzke D, Cirak S, Schachter H, Vajsar J, Voit T, Muntoni F, Strahl S, Mathews K, Nelson S, Moore S, Campbell K.  Patient fibroblast functional complementation studies: a valuable tool in the identification of novel Walker-Warburg syndrome disease genes.  World Muscle Society.  2012 October. 

Talman W, Dragon D, Jones S, Moore S, Lin L.  Sudden death and myocardial lesions after damage to catecholamine neurons of the nucleus tractus solitarii in rat.  Cellular Mol Neurobiol.  2012 October. 32(7):1119-26.
[PubMed]

McGaughey S, Nelson T, Cox M, Moore S.  Evaluation of calpain-3 in patients with limb-girdle muscular dystrophy.  2012 meeting of the American Association of Neuropathologists.  2012 June. 

Martin S, Moore S, bodkin C, Hattab E.  Myofibrillar myopathy with large cores: A case report.  2012 meeting of the American Association of Neuropathologists.  2012 June. 

Moore S, Moore B, Love S, Li J, Lopez M, von der Hagen M, Hubner A, Winder T, Cullup T, Majumdar A, Abdel-Salam H, Siddiqui F, Lung P, Dowling J.  Novel beta-tropomyosin mutation (TPM2) causes distal core-rod myopathy and trismus-pseudocamptodactyly with nemaline rods.  2012 meeting of the American Association of Neuropathologists.  2012 June. 

Moore S, Winder T, Nelson T, Cox M, Reyes C, Tesi-Rocha C, Chang T.  Novel homozygous stop mutation in alphaB crystallin (CRYAB:p.Ser135*) causes fatal congenital form of myofibillar myopathy.  2012 meeting of the American Association of Neuropathologists.  2012 June. 

Acsadi G, Moore S, Chéron A, Delalande O, Bennett L, Kupsky W, El-Baba M, Le Rumeur E, Hubert J.  A novel mutation in spectrin-like repeat 1 of dystrophin central domain causes protein misfolding and mild Becker muscular dystrophy.  J Biol Chem.  2012 May. 287(22):18153-62.
[PubMed]

Willer T, Lee H, Lommel M, Yoshida-Moriguchi T, de Bernabe D, Venzke D, Cirak S, Schachter H, Vajsar J, Voit T, Muntoni F, Loder A, Dobyns W, Winder T, Strahl S, Mathews K, Nelson S, Moore S, Campbell K.  ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome.  Nature Genetics.  2012 May. 44(5):575-80.
[PubMed]

Dialynas G, Flannery K, Zirbel L, Nagy P, Mathews K, Moore S, Wallrath L.  LMNA variants cause cytoplasmic distribution of nuclear pore proteins in Drosophila and human muscle.  Human Molecular Genetics.  2012 April. 21(7):1544-56.
[PubMed]

Eskuri J, Stanley C, Moore S, Mathews K.  Infantile onset CMT2D/dSMA V in monozygotic twins due to a mutation in the anticodon-binding domain of GARS.  J Peripheral Nervous System.  2012 March. 17(1):132-4.
[PubMed]

Joiner M, Koval O, Li J, He B, Allamargot C, Guo Z, Luczak E, Hall D, Fink B, Chen B, Yang J, Moore S, Scholz T, Strack S, MOHLER P, Sivitz W, Song L, Anderson M.  CaMKII determines mitochondrial stress responses in heart.  Nature.  2012. 491:269-273.
[PubMed]

Myshrall T, Moore S, Ostendorf A, Satz J, Kowalczyk T, Nguyen H, Daza R, Lau C, Campbell K, Hevner R.  Dystroglycan on radial glia end feet is required for pial basement membrane integrity and columnar organization of the developing cerebral cortex.  J Neuropathol Exp Neurol.  2012. 71:1047-1063.
[PubMed]

McGaughey S, Nelson T, Cox M, Moore S.  Evaluation of calpain-3 in patients with limb-girdle muscular dystrophy.  J Neuropathol Exp Neurol.  2012. 71:574.

Dowling J, Davidson A, Lopez M, Siddiqui F, Lung P, Li J, Jungbluth H, Love S, Moore S.  Expanding the clinical and genetic phenotype of TPM2-related myopathies.  Neuromusc Disorders.  2012. 22:821.

Martin S, Moore S, bodkin C, Hattab E.  Myofibrillar myopathy with large cores: A case report.  J Neuropathol Exp Neurol.  2012. 71:587.

Moore S, Moore B, Love S, Li J, Lopez M, von der Hagen M, Hubner A, Winder T, Cullup T, Majumdar A, Abdel-Salam H, Siddiqui F, Lung P, Dowling J.  Novel beta-tropomyosin mutation (TPM2) causes distal core-rod myopathy and trismus-pseudocamptodactyly with nemaline rods.  J Neuropathol Exp Neurol.  2012. 71:575.

Moore S, Winder T, Nelson T, Cox M, Reyes C, Tesi-Rocha C, Chang T.  Novel homozygous stop mutation in alphaB crystallin (CRYAB:p.Ser135*) causes fatal congenital form of myofibillar myopathy.  J Neuropathol Exp Neurol.  2012. 71:587-588.

Tesi Rocha C, Taylor M, Chang T, Reyes C, Winder T, Moore S, Bonnemann C, Nelson K.  Novel homozygous stop mutation in alphaB crystalline: expanding the phenotype.  Neuromusc Disorders.  2012. 22:821.

Willer T, Lee H, Lommel M, Yoshida-Moriguchi T, Beltran Valero de Bernabe D, Venzke D, Cirak S, Schachter H, Vajsar J, Voit T, Muntoni F, Strahl S, Mathews K, Nelson S, Moore S, Campbell K.  Patient fibroblast functional complementation studies: a valuable tool in the identification of novel Walker-Warburg syndrome disease genes.  Neuromusc Disorders .  2012. 22:805.

Kazmi S, McComb R, Gokden M, Spuler S, Filho J, Huston K, Gundogdu B, Moore S.  Amyloid myopathy associated with dysferlinopathy: comparison with light chain amyloidosis.  American Association of Neuropathologists Meeting,.  2011 June. 

Siddiqui F, Moore B, von der Hagen M, Winder T, Abdel Salam H, Huebner A, Moore S.  Autosomal dominant core-rod myopathy with a unique phenotypic presentation and a potentially novel genotype.  American Association of Neurologists Meeting.  2011 April. 

Filho J, McComb R, Ansari S, Spuler S, Moore S.  Dysferlinopathy with distal myopathy and intramuscular amyloid deposition.  American Association of Neurologists Meeting.  2011 April. 

Acsadi A, Kupsky W, Moore S, Cheron A, Bennett L, Le Rumeur E, Hubert J.  Novel point mutation in R1 domain of dystrophin gene causes missfolding of dystrophin and Becker's muscular dystrophy.  American Association of Neurologists Meeting.  2011 April. 

Mathews K, Stephan C, Laubenthal K, Moore S.  Steroid response in patients with a dystroglycanopathy.  American Association of Neurologists Meeting.  2011 April. 

Gundogdu B, Rudnicki S, Al-Lahham T, Gokden M, Moore S.  A young patient with amyloid deposits in the muscle.  Carrell-Krusen Neuromuscular Symposium, Dallas, TX.  2011 February. 

Kazmi S, McComb R, Gokden M, Spuler S, Filho J, Huston K, Gundogdu B, Moore S.  Amyloid myopathy associated with dysferlinopathy: comparison with light chain amyloidosis.  J Neuropathol Exp Neurol.  2011. 70:524.

Di Blasi C, Bellafiore E, Salih M, Manzini M, Moore S, Seidahmed M, Mukhtar M, Karrar Z, Walsh C, Campbell K, Mantegazza R, Morandi L, Mora M.  Variable disease severity in Saudi Arabian and Sudanese families with c.3924 + 2 T > C mutation of LAMA2.  BMC Research Notes.  2011. 4:534.
[PubMed]

Mathews K, Stephan C, Laubenthal K, Winder T, Michele D, Moore S, Campbell K.  Myoglobinuria and muscle pain are common in patients with limb-girdle muscular dystrophy 2I.  Neurology.  2011 January. 76(2):194-5.
[PubMed]

Guo L, Moore S, Forcales S, Engvall E, Shelton G.  Evaluation of commercial dysferlin antibodies on canine, mouse and human skeletal muscle.  Neuromuscular Disorders.  2010 December. 20(12):820-5.
[PubMed]

Han R, Frett E, Levy J, Rader E, Lueck J, Bansal D, Moore S, Ng R, Beltrán-Valero de Bernabé D, Faulkner J, Campbell K.  Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice.  J Clin Invest.  2010 December. 120(12):4366-74.
[PubMed]

Yang A, Ng B, Moore S, Raymond K, Freeze H, Mehta L.  DPM1 mutations in a patient with dystrophic muscle and abnormal alpha-dystroglycan.  60th Annual Meeting of the American Society of Human Genetics.  2010 November. 

Darbro B, Cox E, Stence A, CABUAY B, Mathews K, Nagy P, Moore S.  In silico and experimental analysis of a novel intronic LMNA DNA variation implicated in limb girdle muscular dystrophy type 1B and dilated cardiomyopathy.  60th Annual Meeting of the American Society of Human Genetics.  2010 November. 

Satz J, Ostendorf A, Hou S, Turner A, Kusano H, Lee J, Turk R, Nguyen H, Ross-Barta S, Westra S, Hoshi T, Moore S, Campbell K.  Distinct functions of glial and neuronal dystroglycan in the developing and adult mouse brain.  J Neurosci.  2010 October. 30(43):14560-72.
[PubMed]

Mathews K, Nagan M, Moore S, Stephan S.  Progressive childhood-onset hearing loss in FSHD.  Child Neurology Society annual meeting.  2010 October. 

Trantow C, Hedberg-Buenz A, Iwashita S, Moore S, Anderson M.  Elevated oxidative membrane damage associated with genetic modifiers of Lyst-mutant phenotypes.  PLoS genetics.  2010 July. 6(7):e1001008.
[PubMed]

Margeta M, Connolly A, Winder T, Pestronk A, Moore S.  Cardiac pathology exceeds skeletal muscle pathology in two cases of limb-girdle muscular dystrophy type 2I.  Muscle & Nerve.  2009 November. 40(5):883-9.
[PubMed]

Satz J, Philp A, Nguyen H, Kusano H, Lee J, Turk R, Riker M, Hernández J, Weiss R, Anderson M, Mullins R, Moore S, Stone E, Campbell K.  Visual impairment in the absence of dystroglycan.  J Neurosci.  2009 October. 29(42):13136-46.
[PubMed]

Rodríguez-Lebrón E, Gouvion C, Moore S, Davidson B, Paulson H.  Allele-specific RNAi mitigates phenotypic progression in a transgenic model of Alzheimer's disease.  Mol Ther.  2009 September. 17(9):1563-73.
[PubMed]

Han R, Kanagawa M, Yoshida-Moriguchi T, Rader E, Ng R, Michele D, Muirhead D, Kunz S, Moore S, Iannaccone S, Miyake K, McNeil P, Mayer U, Oldstone M, Faulkner J, Campbell K.  Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan.  Proc Natl Acad Sci USA.  2009 August. 106(31):12573-9.
[PubMed]

Nguyen H, Ostendorf A, Satz J, Campbell K, Moore S.  Dystroglycan and cerebellar granule neuron development.  American Association of Neuropathologists Meeting.  2009 June. 

Chang W, Winder T, LeDuc C, Simpson L, Millar W, Dungan J, Ginsberg N, Plaga S, Moore S, Chung W.  Founder Fukutin mutation causes Walker-Warburg syndrome in four Ashkenazi Jewish families.  Prenat Diagn.  2009 June. 29(6):560-9.
[PubMed]

Cox E, Darbro B, Mathews K, Nagy P, CABUAY B, Moore S.  Novel LMNA mutation in a North American family with LGMD1B and dilated cardiomyopathy.  American Association of Neuropathologists Meeting.  2009 June. 

Puckett R, Moore S, Winder T, Willer T, Romansky S, Covault K, Campbell K, Abdenur J.  Further evidence of Fukutin mutations as a cause of childhood onset limb-girdle muscular dystrophy without mental retardation.  Neuromusc Dis.  2009 May. 19(5):352-6.
[PubMed]

Mathews K, Stephan C, Laubenthal K, Moore S.  Muscle pain and myoglobinuria are common in patients with FKRP mutations.  American Academy of Neurology Meeting.  2009 April. 

Nayate A, Moore S, Weiss R, Taktakishvili O, Lin L, Talman W.  Cardiac damage after lesions of the nucleus tractus solitarii.  Am J Physiol Regul Integr Comp Physiol.  2009 February. 296(2):R272-9.
[PubMed]

Darbro B, Arends R, Santiago S, Crouch K, Moore S, Nagy P.  Application of a New Array-Based Comparative Genomic Hybridization Data Analysis Method for Identification of Copy Number Variations in Non-Duchenne/Becker Muscular Dystrophies.  2009 Annual Meeting of the Association for Molecular Pathology.  2009. 

Nguyen H, Ostendorf A, Satz J, Campbell K, Moore S.  Dystroglycan and cerebellar granule neuron development.  J Neuropathol Exp Neurol.  2009. 68:554-555.

Wakefield S, Dimberg E, Moore S, Tseng B.  Dystrophinopathy presenting with arrhythmia in an asymptomatic 34-year-old man: a case report.  J Med Case Reports.  2009. 3:8625.
[PubMed]

Cox E, Darbro B, Mathews K, Nagy P, CABUAY B, Moore S.  Novel LMNA mutation in a North American family with LGMD1B and dilated cardiomyopathy.  J Neuropathol Exp Neurol.  2009. 68:555.

Nguyen H, Ostendorf A, Satz J, Campbell K, Moore S.  Cerebellar granule neuron development in the absence of dystroglycan.  Society for Neuroscience Meeting.  2008 November. 

Mathews K, Stephan C, Laubenthal K, Moore S.  Genotype and phenotype analysis of a North American cohort with FKRP mutations: congenital muscular dystrophy 1C (MDC 1C) and limb girdle muscular dystrophy 2I (LGMD 2I).  Child Neurology Society Meeting.  2008 November. 

Kobayashi Y, Rader E, Crawford R, Iyengar N, Thedens D, Faulkner J, Parikh S, Weiss R, Chamberlain J, Moore S, Campbell K.  Sarcolemma-localized nNOS is required to maintain activity after mild exercise.  Nature.  2008 November. 456(7221):511-5.
[PubMed]

Satz J, Barresi R, Durbeej M, Willer T, Turner A, Moore S, Campbell K.  Brain and eye malformations resembling Walker-Warburg syndrome are recapitulated in mice by dystroglycan deletion in the epiblast.  J Neurosci.  2008 October. 28(42):10567-75.
[PubMed]

Pace R, Peat R, Baker N, Zamurs L, Mörgelin M, Irving M, Adams N, Bateman J, Mowat D, Smith N, Lamont P, Moore S, Mathews K, North K, Lamandé S.  Collagen VI glycine mutations: perturbed assembly and a spectrum of clinical severity.  Ann Neurol.  2008 September. 64(3):294-303.
[PubMed]

Netland J, Meyerholz D, Moore S, Cassell M, Perlman S.  Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2.  J Virology.  2008 August. 82(15):7264-75.
[PubMed]

Kobuke K, Piccolo F, Garringer K, Moore S, Sweezer E, Yang B, Campbell K.  A common disease-associated missense mutation in alpha-sarcoglycan fails to cause muscular dystrophy in mice.  Hum Mol Genet.  2008 May. 17(9):1201-13.
[PubMed]

Moore S, Winder T, Margeta M.  Cardiac Pathology in a Case of Limb-Girdle Muscular Dystrophy Type 2I (LGMD-2I).  Biology and Disease of Skeletal Muscle Meeting.  2008 April. 

Margeta M, Winder T, Moore S.  Cardiac pathology in a case of limb-girdle muscular dystrophy type 2I (LGMD-2I).  Experimental Biology Meeting.  2008 April. 

Moore S, Lamande S, Winder T.  Diagnostic Testing for Congenital Muscular Dystrophies in a Cohort of USA Patients.  Biology and Disease of Skeletal Muscle Meeting.  2008 April. 

Moore S, Lamande S, Winder T.  Diagnostic testing for congenital muscular dystrophies in a cohort of USA patients.  Experimental Biology Meeting.  2008 April. 

Spuler S, Carl M, Zabojszcza J, Straub V, Bushby K, Moore S, Bähring S, Wenzel K, Vinkemeier U, Rocken C.  Dysferlin-deficient muscular dystrophy features amyloidosis.  Ann Neurol.  2008 March. 63(3):323-8.
[PubMed]

Andrade A, Iannaccone S, Burns B, Winder T, Moore S.  Infant girl with microcephaly and motor delay.  30th Annual Carrell-Krusen Neuromuscular Symposium, Texas Scottish Rite Hospital for Children.  2008 February. 

Forst R, Winder T, Moore S, Romansky S, King Covault K, Abdenur J.  Novel Mutations in the Fukuyama Congenital Muscular Dystrophy (FCMD) Gene Associated with a Mild Phenotype.  Society of Inherited Metabolic Disorders.  2008. 

Satz J, Barresi R, Durbeej M, Willer T, Turner A, Moore S, Campbell K.  Epiblast-specific loss of dystroglycan causes brain and eye malformations that resemble Walker-Warburg syndrome.  Symposium on Biological Complexity: Genes, Circuits, and Behavior.  2008 January. 

Ferraris S, Clark S, Garelli E, Davidzon G, Moore S, Kardon R, Bienstock R, Longley M, Mancuso M, Gutiérrez Ríos P, Hirano M, Copeland W, DiMauro S.  Progressive external ophthalmoplegia and vision and hearing loss in a patient with mutations in POLG2 and OPA1.  Arch Neurol.  2008 January. 65(1):125-31.
[PubMed]

Baker N, Peat R, Pace R, Morgein M, Adams N, Irving M, Zamurs L, Bateman J, Moore S, North K, Lamande S.  Genotype-phenotype correlations in the collagen VI muscular dystrophies.  7th Pan Pacific Connective Tissue Societies Symposium.  2007 October. 

Yokoyama T, Lisi T, Moore S, Sluka K.  Muscle fatigue increases the probability of developing hyperalgesia in mice.  J Pain.  2007 September. 8(9):692-9.
[PubMed]

Winder T, Laffin J, Moore S.  Common mutations detected for diagnosis of limb-girdle muscular dystrophy.  Experimental Biology Meeting.  2007 April. 

McComb R, Radio S, McAllister J, Erickson C, Pattee G, Moore S.  Danon disease (autophagocytic vacuolar myopathy): clinicopathologic features of a kindred.  Experimental Biology Meeting.  2007 April. 

Winder T, Stence A, Moore S.  Protein O-mannosyltransferase 1 (POMT1) Mutations in a Patient with Mild Congenital Muscular Dystrophy.  American College of Medical Genetics 2007 Annual Clinical Genetics Meeting .  2007 March. 

Winder T, Laffin J, Moore S.  Common mutations detected for diagnosis of limb-girdle muscular dystrophy.  FASEB J.  2007. 21:A398-399.

McComb R, Radio S, McAllister J, Erickson C, Pattee G, Moore S.  Danon disease (autophagocytic vacuolar myopathy): clinicopathologic features of a kindred.  FASEB J.  2007. 21:A399.

Fang X, Faraci F, Kaduce T, Harmon S, Modrick M, Hu S, Moore S, Falck J, Weintraub N, Spector A.  20-Hydroxyeicosatetraenoic acid is a potent dilator of mouse basilar artery: role of cyclooxygenase.  Am J Physiol Heart Circ Physiol.  2006 November. 291(5):H2301-7.
[PubMed]

Khalsa S, Moore S, Van Hoesen G.  Hughlings Jackson and the role of the entorhinal cortex in temporal lobe epilepsy: from patient A to Doctor Z.  Epilepsy & Behavior .  2006 November. 9(3):524-31.
[PubMed]

Moore S, Ostendorf A, Satz J, Westra S, Ross-Barta S, Campbell K.  Dystroglycan deletion reveals spatial developmental heterogeneity of the cerebellar glia limitans.  2006 Society for Neuroscience Meeting.  2006 October. 

Rodriguez-Lebron E, Gouvion C, Miller V, Moore S, Davidson B, Paulsen H.  In vivo allele-specific silencing of the Swedish APP mutant: development of an RNAi strategy against familial forms of Alzheimer’s disease. .  2006 Society for Neuroscience Meeting.  2006 October. 

Moore S, Shilling C, Westra S, Wall C, Wicklund M, Stolle C, Brown C, Michele D, Piccolo F, Winder T, Stence A, Barresi R, King N, King W, Florence J, Campbell K, Fenichel G, Stedman H, Kissel J, Griggs R, Pandya S, Mathews K, Pestronk A, Serrano C, Darvish D, Mendell J.  Limb-girdle muscular dystrophy in the United States.  J Neuropathol Exp Neurol.  2006 October. 65(10):995-1003.
[PubMed]

Myshrall T, Moore S, Ostendorf A, Satz J, Lau C, Campbell K, Hevner R.  Meningeal heterotopia formation in dystroglycan null mice.  2006 Society for Neuroscience Meeting.  2006 October. 

Yokoyama T, Lisi T, Moore S, Sluka K.  Muscle fatigue enhances mechanical hyperalgesia induced by intramuscular acid injections in mice.  2006 Society for Neuroscience Meeting.  2006 October. 

Nayate A, Moore S, Weiss R, Lin L, Talman W.  Central baroreflex interruption, cardiac toxicity, and sudden death.  Experimental Biology Meeting.  2006 April. 

Satz J, Ostendorf A, Moore S, Eastman C, Mullins R, Stone E, Barresi R, Campbell K.  Dystroglycan is necessary for the formation of basal laminae in the eye and cerebral cortex but is dispensable for the maintenance of the inner limiting membrane of the retina.  2006 Society for Neuroscience Meeting.  2006. 

Occhi S, Zambroni D, Del Carro U, Amadio S, Sirkowski E, Scherer S, Campbell K, Moore S, Chen Z, Strickland S, Di Muzio A, Uncini A, Wrabetz L, Feltri M.  Both laminin and Schwann cell dystroglycan are necessary for proper clustering of sodium channels at nodes of Ranvier.  J Neurosci.  2005 October. 25(41):9418-27.
[PubMed]

Collins X, Harmon S, Kaduce T, Berst K, Fang X, Moore S, Raju T, Falck J, Weintraub N, Duester G, Plapp B, Spector A.  Omega-oxidation of 20-hydroxyeicosatetraenoic acid (20-HETE) in cerebral microvascular smooth muscle and endothelium by alcohol dehydrogenase 4.  J Biol Chem.  2005 September. 280(39):33157-64.
[PubMed]

Apostolova L, White M, Moore S, Davis P.  Deep white matter pathologic features in watershed regions: a novel pattern of central nervous system involvement in MELAS.  Arch Neurol.  2005 July. 62(7):1154-6.
[PubMed]

Ostendorf A, Satz J, Westra S, Ross-Barta S, Campbell K, Moore S.  Abnormal cerebral histogenesis following deletion of dystroglycan.  81st Annual Meeting of the American Association of Neuropathologists.  2005 June. 

Ostendorf A, Satz J, Westra S, Ross-Barta S, Campbell K, Moore S.  Abnormal cerebral histogenesis following deletion of dystroglycan.  J Neuropathol Exp Neurol.  2005. 64(64):446.

Talman W, Nayate A, Moore S, Weiss R, Lin L.  Central neurogenic cardiac toxicity.  American Association of Neurologists meeting..  2005. 

Shilling C, Darvish D, Moore S, Kissel J, king W, Xiomara Rosales X, Wall C, Mendell J.  Phenotypic marker variability in calpainopathy patients of North American.  American Association of Neurologists meeting.  2005. 

Chen P, Hu S, Yao J, Moore S, Spector A, Fang X.  Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium.  Microvascular Res.  2005 January. 69(2-Jan):28-35.
[PubMed]

Satz J, Moore S, Barresi R, Eastman C, Ross-Barta S, Westra S, Patterson M, Mullins R, Stone E, Campbell K.  Complete loss of dystroglycan in the mouse CNS causes brain and eye defects similar to congenital muscular dystrophies.  Society for Neuroscience Meeting.  2004 October. 

Ostendorf A, Satz J, Westra S, Ross-Barta S, Campbell K, Moore S.  Abnormal cerebral histogenesis in mice following deletion of dystroglycan.  Medial Student Research Day, The University of Iowa.  2004 September. 

Barresi R, Michele D, Kanagawa M, Harper H, Dovico S, Satz J, Moore S, Zhang W, Schachter H, Dumanski J, Cohn R, Nishino I, Campbell K.  LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies.  Nature Medicine.  2004 July. 10(7):696-703.
[PubMed]

Moore S, Ross-Barta S, Westra S, Saito F, Messing A, Bajenaru M, Gutmann D, Campbell K.  Cerebellar dysgenesis correlates with the timing and extent of dystroglycan deletion in conditional knockout mice.  80th Annual Meeting of the American Association of Neuropathologists .  2004 June. 

Moore S, Shilling C, Westra S, Wicklund M, Brown C, Michele D, Stolle C, Campbell K, Fenichel G, Griggs R, Kissel J, Mathews K, Pestronk A, Wal C, Mendell J.  Limb-Girdle Muscular Dystrophy in the USA: distribution of immunophenotypes and genotypes from an ongoing multi-center collaborative study.  American Association of Neuropathology Meeting.  2004 June. 

Moore S, Ross-Barta S, Westra S, Saito F, Messing A, Bajenaru M, Gutmann D, Campbell K.  Cerebellar dysgenesis correlates with the timing and extent of dystroglycan deletion in conditional knockout mice.  J Neuropathol Exp Neurol .  2004. 63:519.

Moore S, Shilling C, Westra S, Wicklund M, Brown C, Michele D, Stolle C, Campbell K, Fenichel G, Griggs R, Kissel J, Mathews K, Pestronk A, Wal C, Mendell J.  Limb-Girdle Muscular Dystrophy in the USA: distribution of immunophenotypes and genotypes from an ongoing multi-center collaborative study.  J Neuropathol Exp Neurol.  2004. 63:532.

Mathews K, Moore S.  Multiminicore myopathy, central core disease, malignant hyperthermia susceptibility, and RYR1 mutations: one disease with many faces?.  Arch Neurol.  2004. 61(1):27-9.
[PubMed]

Chen P, Hu S, Harmon S, Moore S, Spector A, Fang X.  Metabolism of anandamide in cerebral microvascular endothelial cells.  Prostaglandins Other Lipid Mediat.  2004 January. 73(2-Jan):59-72.
[PubMed]

Moore S, Ross-Barta S, Westra S, Saito F, Messing A, Bagenaru M, Gutmann D, Campbell K.  Severity of cerebellar dysgenesis correlates with the timing and extent of dystroglycan deletion in conditional knockout mice.  Society for Neuroscience Meeting.  2003 November. 

Saito F, Moore S, Barresi R, Henry M, Messing A, Ross-barta S, Cohn R, Williamson R, Sluka K, Sherman D, Brophy P, Schmelzer J, Low P, Wrabetz L, Feltri M, Campbell K.  A role for schwann cell dystroglycan in both myelination and nodal structure.  XVth International Congress of Neuropathology.  2003 September. 

Moore S, Ross-Barta S, Westra S, Saito F, Campbell K.  Early, Progressive disruption of the glia limitans leads to cerebellar dysgenesis in dystroglycan-null mice.  XVth International Congress of Neuropathology.  2003 September. 

Radhakrishnan R, Moore S, Sluka K.  Unilateral carrageenan injection into muscle or joint induces chronic bilateral hyperalgesia in rats.  Pain.  2003 August. 104(3):567-77.
[PubMed]

Saito F, Moore S, Barresi R, Henry M, Messing A, Ross-Barta S, Cohn R, Williamson R, Sluka K, Sherman D, Brophy P, Schmelzer J, Low P, Wrabetz L, Feltri M, Campbell K.  Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization.  Neuron.  2003 June. 38(5):747-58.
[PubMed]

Mathews K, Moore S.  Limb Girdle Muscular Dystrophy.  Current Neurology and Neuroscience Reports .  2003. 3:78-85.
[PubMed]

Girnun G, Domann F, Moore S, Robbins M.  Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter.  Mol Endocrinol.  2002 December. 16(12):2793-801.
[PubMed]

Sluka K, Moore S, Lisi T, Radhakrishnan R.  Long term hyperalgesia and histological changes in rats injected with carrageenan into joint or muscle.  Society for Neuroscience Meeting.  2002 November. 

Berg D, Zhang J, Weinstock J, Ismail H, Earle K, Alila H, Pamukcu R, Moore S, Lynch R.  Rapid development of colitis in NSAID-treated IL-10-deficient mice.  Gastroenterology.  2002 November. 123(5):1527-42.
[PubMed]

Fang X, Chen P, Moore S.  The oxygen radical scavenger pyrrolidine dithiocarbamate enhances interleukin-1beta-induced cyclooxygenase-2 expression in cerebral microvascular smooth muscle cells.  Microvascular research.  2002 November. 64(3):405-13.
[PubMed]

Cohn R, Henry M, Michele D, Barresi R, Saito F, Moore S, Flanagan J, Skwarchuk M, Robbins M, Mendell J, Williamson R, Campbell K.  Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration.  Cell.  2002 September. 110(5):639-48.
[PubMed]

Moore S, Saito F, Chen J, Michele D, Henry M, Messing A, Cohn R, Ross-Barta S, Westra S, Williamson R, Hoshi T, Campbell K.  Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy.  Nature.  2002 July. 418(6896):422-5.
[PubMed]

Michele D, Barresi R, Kanagawa M, Saito F, Cohn R, Satz J, Dollar J, Nishino I, Kelley R, Somer H, Straub V, Mathews K, Moore S, Campbell K.  Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.  Nature.  2002 July. 418(6896):417-22.
[PubMed]

Moore S, Saito F, Henry M, Messing A, Low P, Wrabetz L, Feltri L, Campbell K.  Peripheral neuropathy with folded myelin sheaths in mice lacking Schwann cell dystroglycan.  78th Annual Meeting of the American Association of Neuropathologists in Denver, CO.  2002 June. 

Saito F, Moore S, Henry M, Messing A, Ross-Barta S, Cohn R, Williamson R, Sluka K, Sherman D, Brophy P, Schmelzer J, Low P, Wrabetz L, Feltri M, Campbell K.  Peripheral neuropathy with folded myelin sheaths in mice lacking Schwann cell dystroglycan.  JAX Workshop on Mouse Molecular Neurogenetics.  2002 June. 

Allamand V, Campbell K, Mendell J, Moore S, Periquet I, Novak V, Stedman H, Stolle C, Wall C, Wilson J.  Clinical trial of gene transfer for limb girdle muscular dystrophy type 2D (alpha-sarcoglycan deficiency).  54th Annual Meeting of the American Academy of Neurology.  2002 May. 

Bailey M, Dickerson L, Moore S, Schutte B, Lamb F.  CFTR/CIC-3 double knockout mice display dramatically increased mortality.  FASEB J.  2002. 

Bilunas M, Moore S.  Cyclooxygenase-2 expression and activity are induced by amyloid-beta 1-42 in brain-derived cells.  Plenum Publishing Corp., New York, NY, Adv Exp Med Biol.  2002. 507:93-99.

Moore S, Saito F, Henry M, Messing A, Low P, Wrabetz L, Feltri L, Campbell K.  Peripheral neuropathy with folded myelin sheaths in mice lacking Schwann cell dystroglycan.  J Neuropathol Exp Neurol.  2002. 61:485.

Hindman B, Moore S, Cutkomp J, Smith T, Ross-Barta S, Dexter F, Brian J.  Brain expression of inducible cyclooxygenase 2 messenger RNA in rats undergoing cardiopulmonary bypass.  Anesthesiology.  2001 December. 95(6):1380-8.
[PubMed]

Moore S, Saito F, Henry M, Messing A, Cohn R, Williamson R, Campbell K.  Abnormal brain development following selective deletion of dystroglycan.  Society for Neuroscience.  2001 November. 

Preuss M, Weydert C, Spitz D, Oberley L, Moore S, Robbins M.  Adaptation of Superoxide Dismutase Enzymatic Activity Assay to a Microtiter Plate.  Oxygen Society 8th Annual Meeting.  2001 November. 

Grzybicki D, Liu Y, Moore S, Brown H, Silverman J, D'Amico F, Raab S.  Interobserver variability associated with the MIB-1 labeling index: high levels suggest limited prognostic usefulness for patients with primary brain tumors.  Cancer.  2001 November. 92(10):2720-6.
[PubMed]

Saito F, Moore S, Henry M, Messing A, Cohn R, Williamson R, Wrabetz L, Feltri M, Campbell K.  Schwann cell specific ablation of dystroglycan gene: A role for dystroglycan/laminin interaction in peripheral nervous system.  Society for Neuroscience Meeting.  2001 November. 

Moore S, Saito F, Henry M, Messing A, Cohn R, Williamson R, Campbell K.  Abnormal brain development in mice after selective deletion of dystroglycan.  Fourth Workshop on Mouse Molecular Neurogenetics.  2001 September. 

Moore S, SAito F, Henry M, Messing A, Cohn R, Williamson R, Campbell K.  Brain developmental abnormalities following selective deletion of dystroglycan.  World Muscle Conference.  2001 September. 

Williard D, Harmon S, Kaduce T, Preuss M, Moore S, Robbins M, Spector A.  Docosahexaenoic acid synthesis from n-3 polyunsaturated fatty acids in differentiated rat brain astrocytes.  J Lipid Res.  2001 September. 42(9):1368-76.
[PubMed]

Barresi R, Moore S, Stolle C, Mendell J, Campbell K.  Expression of -sarcoglycan in smooth muscle and its interaction with the smooth muscle sarcoglycan-sarcospan complex.  World Muscle Conference.  2001 September. 

Cohn R, Henry M, Barresi R, Moore S, Skwarchuk M, Robbins M, Lee J, Kahn C, Williamson R, Campbell K.  Muscle-specific disruption of dystroglycan: insights into muscular dystrophy and muscle regeneration.  World Muscle Conference.  2001 September. 

Afifi A, Follett K, Greenlee J, Scott W, Moore S.  Optic neuritis: a novel presentation of Schilder's disease.  J Child Neurol.  2001 September. 16(9):693-6.
[PubMed]

Chen Y, Zhang J, Moore S, Ballas Z, Portanova J, KRIEG A, Berg D.  CpG DNA induces cyclooxygenase-2 expression and prostaglandin production.  Int Immunol.  2001 August. 13(8):1013-20.
[PubMed]

Moore S, Saito F, Henry M, Messing A, Cohn R, Williamson R, Campbell K.  Selective deletion of brain dystroglycan results in neuronal migration errors.  77th Annual Meeting of the American Association of Neuropathologists .  2001 June. 

Brian J, Faraci F, Moore S.  COX-2-dependent delayed dilatation of cerebral arterioles in response to bradykinin.  Am J Physiol Heart Circ Physiol.  2001 May. 280(5):H2023-9.
[PubMed]

Felice K, Moore S.  Unusual clinical presentations in patients harboring the facioscapulohumeral dystrophy 4q35 deletion.  Muscle & nerve.  2001 March. 24(3):352-6.
[PubMed]

Berg D, Zhang J, Lauricella D, Moore S.  Il-10 is a central regulator of cyclooxygenase-2 expression and prostaglandin production.  J Immunol.  2001 February. 166(4):2674-80.
[PubMed]

Watkins P, Hamilton J, Leaf A, Spector A, Moore S, Anderson R, Moser H, Noetzel M, Katz R.  Brain uptake and utilization of fatty acids: applications to peroxisomal biogenesis diseases.  J Mol Neurosci.  2001. 16:87-92.
[PubMed]

Katz R, Hamilton J, Spector A, Moore S, Moser H, Noetzel M, Watkins P.  Brain uptake and utilization of fatty acids: recommendations for future research..  J Mol Neurosci.  2001. 16:333-335.
[PubMed]

Berg D, Lynch R, Moore S.  IL-10 is a central regulator of cyclooxygenase expression and prostaglandin production.  FASEB J.  2001. 

Piccolo F, Moore S, Mathews K, Campbell K.  Limb-girdle muscular dystrophies.  Lippencott Williams & Wilkins, Philadelphia. Adv Neurol .  2001. 88:273-291.

Wickland M, Moore S, Campbell K, Mathews K, Wall C, Shilling C, King N, King W, Serrano C, Kissel J, Fenichel G, Griggs R, Pestronk A, Stedman H, Stolle D, Mendell J.  Molecular and clinical characterization of individuals with limb-girdle muscular dystrophy.  American Academy of Neurology Meeting.  2001. 

Moore S.  Polyunsaturated fatty acid synthesis and release by brain-derived cells in vitro.  J Mol Neurosci.  2001. 16:195-200.
[PubMed]

Williard D, Harmon S, Preuss M, Kaduce T, Moore S, Spector A.  Production and release of docosahexaenoic acid by differentiated rat brain astrocytes.  World Rev Nutr Diet .  2001. 88:168-172.

Moore S, Saito F, Henry M, Messing A, Cohn R, Williamson R, Campbell K.  Selective deletion of brain dystroglycan results in neuronal migration errors.  J Neuropathol Exp Neurol.  2001. 60:512.

Cohn R, Durbeej M, Moore S, Coral-Vazquez R, Prouty S, Campbell K.  Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex.  J Clin Invest.  2001 January. 107(2):R1-7.
[PubMed]

Sluka K, Kalra A, Moore S.  Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia.  Muscle & nerve.  2001 January. 24(1):37-46.
[PubMed]

Barresi R, Moore S, Stolle C, Mendell J, Campbell K.  Expression of gamma -sarcoglycan in smooth muscle and its interaction with the smooth muscle sarcoglycan-sarcospan complex.  J Biol Chem.  2000 December. 275(49):38554-60.
[PubMed]

Piccolo F, Moore S, Ford G, Campbell K.  Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies.  Ann Neurol.  2000 December. 48(6):902-12.
[PubMed]

Kasparcova V, Mendell J, Wall C, Wilson J, Moore S, Campbell K, Piccolo F, McCullough B, Stolle C.  Analysis of mutations in the sarcoglycan genes in patients with limb-girdle muscular dystrophy.  Am. Soc. Human Genetics Meeting.  2000 November. 

Bilunas M, Moore S.  Induction of cyclooxygenase-2 by amyloid-beta peptide: the role of nitric oxide, cytokines, and reactive oxygen species.  Society for Neuroscience Meeting.  2000 November. 

Fang X, Moore S, Nwankwo J, Weintraub L, Oberley W, Snyder D, Spector A.  Induction of cyclooxygenase-2 by overexpression of the human catalase gene in cerebral microvascular endothelial cells.  J Neurochem.  2000 August. 75(2):614-23.
[PubMed]

Crosbie R, Lim L, Moore S, Hirano M, Hays A, Maybaum S, Collin H, Dovico S, Stolle C, Fardeau M, Tomé F, Campbell K.  Molecular and genetic characterization of sarcospan: insights into sarcoglycan-sarcospan interactions.  Hum Mol Genetics.  2000 August. 9(13):2019-27.
[PubMed]

Felice K, North W, Moore S, Mathews K.  FSH dystrophy 4q35 deletion in patients presenting with facial-sparing scapular myopathy.  Neurology.  2000 May. 54(10):1927-31.
[PubMed]

Williard D, Harmon S, Preuss M, Kaduce T, Moore S, Spector A.  Differentiated astrocytes retain the capacity to form docosahexaenoic acid from n-3 fatty acid precursors.  International Workshop on Brain Uptake & Metabolism of Fatty Acids: Application to Peroxisomal Biogenesis Disorders.  2000 March. 

Piccolo F, Bansal D, Moore S, Campbell K.  Dysferlin expression in Duchenne and limb-girdle muscular dystrophies.  International Congress of Myology.  2000 March. 

Moore S, Bilunas M.  Amyloid-beta peptide induces cyclooxygenase-2 expression and activity in brain-derived cells.  J Neuropathol Exp Neurol.  2000. 59:448.

Hindman B, Moore S, Cutkomp J, Smith T.  Cardiopulmonary bypass (CPB) increases brain inducible cyclooxygenase (COX2) mRNA expression in rats.  Society of Anesthesiologists 2000 Annual Meeting..  2000. 

Moore S, Ross-Barta S, Weydert J, Yoder E.  COX-2 expression in cerebral endothelium: a delayed effect of bradykinin.  J Neuropathol Exp Neurol.  2000. 59:459.

Durbeej M, Cohn R, Hrstka R, Moore S, Allamand V, Davidson B, Williamson R, Campbell K.  Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E.  Molecular cell.  2000 January. 5(1):141-51.
[PubMed]

Fang X, Moore S, Weintraub N, Snyder G, Kaduce T, Spector A.  Antioxidant enhances interleukin-1 induced COX-2 expression in cerebral microvascular smooth muscle cells.  72nd Scientific Sessions of the American Heart Association.  1999 November. 

Cohn R, Coral R, Moore S, Hill J, Weiss R, Davisson R, Straub V, Bansal D, Williamson R, Campbell K.  Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism in the pathogenesis of ischemic cardiomyopathy and muscular dystrophy.  72nd Scientific Sessions of the American Heart Association.  1999 November. 

Sluka K, kalra A, Moore S.  A new model of chronic muscle pain.  Society for Neuroscience Meeting.  1999 October. 

Hilfers M, Moore S.  Amyloid-beta peptide induces cyclooxygenase-2 expression and activity in brain-derived cells.  Society for Neuroscience Meeting.  1999 October. 

Coral-Vazquez R, Cohn R, Moore S, Hill J, Weiss R, Davisson R, Straub V, Barresi R, Bansal D, Hrstka R, Williamson R, Campbell K.  Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy.  Cell.  1999 August. 98(4):465-74.
[PubMed]

Moore S, Coral R, Cohn R, Straub V, Williamson R, Campbell K.  Severe muscular dystrophy and cardiomyopathy in mice deficient in delta-sarcoglycan.  75th Annual Meeting of the American Association of Neuropathologists in Portland, OR.  1999 June. 

Girnum G, Domann F, Moore S, Robbins M.  Nuclear hormone receptors and polyunsaturated fatty acids modulate catalase gene expression.  AACR Annual Meeting.  1999 April. 

Moore S, Weydert J, Yoder E, Faraci F, Brian Jr J.  Bradykinin induces COX-2 in cerebral endothelium .  GASEB j.  1999. 13:A1072.

Yoder E, Rich G, Hilfers M, Albright J, Weydert J, Moore S.  Cerebrovascular cyclooxygenase-2 (COX-2) is regulated by pro- and anti-inflammatory agents.  J Neuropathol Exp Neurol.  1999. 58:542.

Brian Jr J, Moore S, Faraci F.  COX-2 mediated effects of bradykinin in cerebral arterioles.  FASEB J.  1999. 13:A1072.

Girnun G, Moore S, Oberley L, Robbins M.  Eicosapentaenoic acid alters Mn-SOD levels in normal but not malignant CNS-derived cells.  Plenum Publishing Corp., New York, NY, Adv Exp Med Biol .  1999. 469:647-653.

Grzybicki D, Moore S.  Implications of prognostic markers in brain tumors.  Clin Lab Med.  1999. 19:833-847.

Moore S, Yoder E, Rich G, Hilfers M, Albright J.  Regulation of cerebrovascular cyclooxygenase-2 by pro- and anti-inflammatory cytokines.  Plenum Publishing Corp., Adv Exp Med Biol .  1999. 269:125-130.

Moore S, Coral R, Cohn R, Straub V, Williamson R, Campbell K.  Severe muscular dystrophy and cardiomyopathy in mice deficient in delta-sarcoglycan.  J Neuropathol Exp Neurol.  1999. 58:527.

Fang X, Moore S, Stoll L, Rich G, Kaduce T, Weintraub N, Spector A.  14,15-Epoxyeicosatrienoic acid inhibits prostaglandin E2 production in vascular smooth muscle cells.  Am J Physiol.  1998 December. 275(6 Pt 2):H2113-21.
[PubMed]

Brian J, Moore S, Faraci F.  Expression and vascular effects of cyclooxygenase-2 in brain.  Stroke; a journal of cerebral circulation.  1998 December. 29(12):2600-6.
[PubMed]

Fang X, Weintraub N, Moore S, Kaduce T, Spector A.  14,15-Epoxyeicosatrienoic acid enhances platelet-derived growth factor-induced vascular smooth muscle cell proliferation.  71st Scientific Sessions of the American Heart Association.  1998 November. 

Moore S, Yoder E, Campbell I, Murphy S.  Cerebrovascular cyclooxygenase-2 (COX-2) is induced by activated astrocytes.  Society for Neuroscience Meeting.  1998 November. 

Hilfers M, Moore S.  Cyclooxygenase-2 expression and activity are blunted in nitric oxide synthase-2 null astrocytes.  Society for Neuroscience Meeting.  1998 November. 

Bohlken D, Alden B, Moore S.  Detection of chromosome 4q35 deletion associated with facioscapulohumeral muscular dystrophy (FSHD) by Southern blot analysis.  Association for Molecular Pathology Annual Meeting.  1998 November. 

Duclos F, Straub V, Moore S, Venzke D, Hrstka R, Crosbie R, Durbeej M, Lebakken C, Ettinger A, van der Meulen J, Holt K, Lim L, Sanes J, Davidson B, Faulkner J, Williamson R, Campbell K.  Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice.  J Cell Biol.  1998 September. 142(6):1461-71.
[PubMed]

Rich G, Yoder E, Moore S.  Regulation of prostaglandin H synthase-2 expression in cerebromicrovascular smooth muscle by serum and epidermal growth factor.  J Cell Physiol.  1998 September. 176(3):495-505.
[PubMed]

Garell P, Menezes A, Baumbach G, Moore S, Nelson G, Mathews K, Afifi A.  Presentation, management and follow-up of Schilder's disease.  Pediatr Neurosurg.  1998 August. 29(2):86-91.
[PubMed]

Moore S, Yoder E, Campbell I, Murphy S.  Cerebral endothelial cyclooxygenase-2 (COX-2) is induced by cytokine-activated astrocytes.  FASEB J.  1998. 12:A674.

Bohlken D, Alden B, Moore S.  Detection of chromosome 4q35 deletion associated with facioscapulohumeral muscular dystrophy (FSHD) by Southern blot analysis.  Am J Pathol.  1998. 153:1650.

Spector A, Moore S, Yorek M.  Docosahexaenoic acid metabolism and function in the central nervous system: studies with cell culture model systems.  AOCS Press, Champaign IL.  1998. 

Grzybicki D, Moore S, Schelper R, Glabinski A, Ransohoff R, Murphy S.  Expression of monocyte chemoattractant protein (MCP-1) and nitric oxide synthase-2 following cerebral trauma.  Acta neuropathologica.  1998 January. 95(1):98-103.
[PubMed]

Gard A, Pennica D, Moore S, Ford O.  Cardiotrophin-1 induces an astrocyte phenotype in cultured oligodendrocyte progenitors.  Society for Neuroscience Meeting.  1997 October. 

Moore S, Yoder E, Rich G.  Cerebrovascular cyclooxygenase-2 expression is regulated by pro- and anti-inflammatory cytokines.  Society for Neuroscience Meeting.  1997 October. 

Hilfers M, Moore S.  Docosahexaenoate enhances the TNF induction of cyclooxygenase-2 in cerebral endothelium.  Society for Neuroscience Meeting.  1997 October. 

Girnun G, Moore S, Oberley L, Robbins M.  Eicosapentaenoic acid alters Mn-SOD levels in normal but not malignant CNS-derived cells. .  5th International Conference on Eicosanoids & Other Bioactive Lipids in Cancer, Inflammation and Related Diseases.  1997 September. 

Moore S, Yoder E, Rich G, Albright J.  Regulation of cerebrovascular cyclooxygenase-2 by pro- and anti-inflammatory cytokines.  5th International Conference on Eicosanoids & Other Bioactive Lipids in Cancer, Inflammation and Related Diseases.  1997 September. 

Sawin P, Traynelis V, Rich G, Smith B, Maves T, Follett K, Moore S.  Chymopapain-induced reduction of proinflammatory phospholipase A2 activity and amelioration of neuropathic behavioral changes in an in vivo model of acute sciatica.  J Neurosurg.  1997 June. 86(6):998-1006.
[PubMed]

Xu J, Wu Y, He L, Yang Y, Moore S, Hsu C.  Regulation of cytokine-induced iNOS expression by a hairpin oligonucleotide in murine cerebral endothelial cells.  Biochem Biophys Res Commun.  1997 June. 235(2):394-7.
[PubMed]

Mathews K, Moore S, Straub V, Mills K, Campbell K.  Immunohistochemical analysis of myodystrophy mouse muscle.  American Association of Neurologists.  1997 February. 

Menezes A, Garell C, Baumbach G, Moore S, Afifi A, Mathews K.  Myelinoclastic diffuse sclerosis (Schilder’s disease) presenting a intracranial masses in childhood.  Joint Section on Pediatric Neurological Surgery.  1996 December. 

Shafer R, Moore S, Campbell I, Murphy S.  Activated astrocytes induce nitric oxide synthase-2 expression in cerebrovascular endothelial cells.  Society for Neuroscience Meeting.  1996 November. 

Moore S, Yoder E, Rich G.  Cytokines regulate prostaglandin H sythase-2 in cerebral microvascular endothelium.  Society for Neuroscience Meeting.  1996 November. 

Grzybicki D, Loihl A, Kardos S, Schelper R, Moore S, Glabinski A, Ransohoff R, Murphy S.  Expression of chemokines and nitric oxide synthase-2 following cerebral trauma.  Society for Neuroscience Meeting.  1996 November. 

Mills K, Moore S, Tresnak J, Mathews K.  Physical mapping around the myodystrophy locus on mouse chromosome 8.  10th International Mouse Genome Conference.  1996 October. 

Spector A, Moore S.  Role of docosahexaenoic acid in the brain.  Lipid Forum at the Norwegian Academy for Science and Letters - “Interconversion of polyunsaturated fatty acids, and their functions in membranes.” .  1996 October. 

Moore S, Yoder E, Rich G.  Prostaglandin H synthase expression in cultured cerebral vascular endothelium and smooth muscle.  Frontiers in Bioactive Lipids '96 (XVIth Washington International Spring Symposium).  1996 May. 

Rich G, Yoder E, Prokuski L, Moore S.  Prostaglandin production in cultured cerebral microvascular smooth muscle is serum dependent.  The American journal of physiology.  1996 May. 270(5 Pt 1):C1379-87.
[PubMed]

Sawin P, Traynelis V, Rich G, Smith B, Maves T, Follett K, Moore S.  Inhibition of phospholipase A2 activity by chymopapain in an in vivo model of acute sciatica.  1996. 

Moore S, Yoder E, Rich G.  Prostaglandin H synthase expression in cultured cerebral endothelium.  FASEB J.  1996. 10:A585.

Rich G, Yoder E, Moore S.  Regulation of prostaglandin H synthase-2 expression in cerebral microvascular smooth muscle by serum and EGF.  FASEB J.  1996. 10:A302.

Moore S, Hurt E, Yoder E, Sprecher H, Spector A.  Docosahexaenoic acid synthesis in human skin fibroblasts involves peroxisomal retroconversion of tetracosahexaenoic acid.  J Lipid Res.  1995 November. 36(11):2433-43.
[PubMed]

Rich G, Prokuski L, Yoder E, Moore S.  Epidermal growth factor induces prostaglandin H synthase-2 in cerebral microvascular smooth muscle.  Society for Neuroscience Meeting.  1995 November. 

Simon J, Baum J, Moore S, Kasson B.  Arginine vasopressin stimulates protein synthesis but not proliferation of cultured vascular endothelial cells.  J Cardiovasc Pharmacol.  1995 March. 25(3):368-75.
[PubMed]

Muhonen M, Piper J, Moore S, Menezes A.  Cervical epidural hematoma secondary to an extradural vascular malformation in an infant: case report.  Neurosurgery.  1995 March. 36(3):585-7; discussion 587-8.
[PubMed]

Rich G, Prokuski L, Yoder L, Moore S.  Cultured cerebral microvascular smooth muscle express prostaglandin H synthase-2.  FASEB J.  1995. 9:A374.

Yoder E, VanRollins M, Moore S.  Epoxyeicosatrienoic acid (EET) metabolism by cerebral endothelium.  FASEB J.  1995. 9:A374.

Slagel D, Goeken J, PLATZ C, Moore S.  Primary germinoma of the spinal cord: a case report with 28-year follow-up and review of the literature.  Acta neuropathologica.  1995. 90(6):657-9.
[PubMed]

Moore S, Yoder L.  Prostaglandin H synthase-2 (PGHS-2) is induced in mouse brain following freeze injury.  FASEB J.  1995. 9:A381.

Moore S.  Targeting of omega-3 fatty acids and synthesis of docosahexaenoic acid at the blood-brain barrier.  American Heart Association Conference Proceedings..  1995. 

Afifi A, Bell W, Menezes A, Moore S.  Myelinoclastic diffuse sclerosis (Schilder's disease): report of a case and review of the literature.  J Child Neurol.  1994 October. 9(4):398-403.
[PubMed]

Moore S, Ionasescu V.  Giant axonal neuropathy: A case study suggesting selective neuronal vulnerability.  12th International Congress of Neuropathology.  1994 September. 

Murphy S, Rich G, Orgren K, Moore S, Faraci F.  Astrocyte-derived lipoxygenase product evokes endothelium-dependent relaxation of the basilar artery.  Journal of neuroscience research.  1994 June. 38(3):314-8.
[PubMed]

Moore S, Hurt E, Yoder E, Gordon J, Spector A.  Docosahexaenoate synthesis requires peroxisomal fatty acid retroconversion.  AHA Scientific Conference on Omega-3 Fatty Acids in Nutrition, Vascular Biology, and Medicine.  1994 April. 

Moore S.  Targeting of omega-3 fatty acids and synthesis of docosahexaenoic acid at the blood-brain barrier.  AHA Scientific Conference on Omega-3 Fatty Acids in Nutrition, Vascular Biology, and Medicine.  1994 April. 

Rich G, Murphy S, Orgren K, Faraci F, Moore S.  Astrocytes release a factor which stimulates endothelial nitric oxide production.  FASEB J.  1994. 8:A28.

Spector A, Gordon J, Moore S, Kaduce T.  Beta-oxidation of HETEs: a peroxisomal process .  World Rev Nutr Diet .  1994. 75:8-15.

Moore S, Ionasescu V.  Giant axonal neuropathy: A case study suggesting selective neuronal vulnerability.  Brain Pathol.  1994. 4:537.

Fitzsimmons K, Moore S.  Kuf's disease presenting as spinocerebellar degeneration.  Brain Pathol.  1994. 4:456.

Moore S.  Local synthesis and targeting of essential fatty acids at the cellular interface between blood and brain - a role for cerebral endothelium and astrocytes in the accretion of CNS docosahexaenoic acid.  World Rev Nutr Diet .  1994. 75:128-133.

Moore S, Hurt E, Yoder E, Gordon J, Spector A.  Peroxisomal fatty acid retroconversion in the synthesis of docosahexaenoic acid.  FASEB J.  1994. 8:A659.

Moore S, Kirk J, Ethel E.  Pharmacologic and RT-PCR characterization of muscarinic receptors in mouse cerebral microvascular smooth muscle.  FASEB J.  1994. 8:A29.

Moore S.  Schwann cell heterogeneity - might it underlie the diversity seen in Schwann cell tumors?.  Human Pathol.  1994. 25:1113.

Xu J, Zhang P, Moore S, Hsu C, Hogan E.  Bradykinin-stimulated phosphoinositide turnover and prostacyclin production regulated by phorbol ester and calcium in cerebral endothelial cells.  Society for Neuroscience Meeting.  1993 November. 

Moore S, Sprecher H, Spector A.  Docosahexaenoic acid (22:6-3) synthesis from 24-carbon precursors in cerebral endothelium.  1st International Congress of the Intern. Soc. for the Study of Fatty Acids and Lipids, Lugano, Switzerland.  1993 June. 

Moore S.  Local synthesis and targeting of essential fatty acids at the cellular interface between blood and brain - a role for cerebral endothelium and astrocytes in the accretion of CNS docosahexaenoic acid.  1st International Congress of the International Society for the Study of Fatty Acids and Lipids, Lugano, Switzerland.  1993 June. 

Moore S, Sprecher H, Spector A.  Synthesis of docosahexaenoic acid (22:6-3) by astrocytes is independent of ∆4-desaturase.  1st International Congress of the Internat. Soc. for the Study of Fatty Acids and Lipids, Lugano, Switzerland, .  1993 June. 

Rogers J, Sato Y, Moore S, Afifi A, Bell W, Menezes A.  Schilder's disease mimicking brain tumor.  American Society of Neuroradiology.  1993 May. 

Moore S, Hurt E, Sprecher H, Spector A.  Docosahexaenoic acid (22:63) synthesis in astrocytes does not require ∆4-desaturase activity.  American Society for Neurochemistry Meeting.  1993 March. 

Simon J, Baum J, Moore S, Johnson A, Kasson B.  Arginine vasopressin (AVP) stimulates protein synthesis but not cell division in mouse cerebral vascular endothelial and smooth muscle cells.  FASEB J.  1993. 7:A750.

Moore S.  Cerebral endothelium and astrocytes cooperate in supplying docosahexaenoic acid to neurons.  Adv Exp Med Biol.  1993. 331:229-233.

Moore S, Hurt E, Sprecher H, Spector A.  Docosahexaenoic acid (22:6-3) synthesis from -3, 24-carbon precursors in cerebral endothelium.  FASEB J.  1993. 7:A383.

Ghoneim S, Waldschmidt T, Yoder L, Moore S, Baumbach G.  Effect of cyclical stretching on cultured rat cerebral vascular smooth muscle cells: a flow cytometric, confocal laser scanning, and transmission electron microscopy study.  Proceedings of the 51st Annual Meeting of the Microscopy Society of America.  1993. 

Spector A, Moore S, North L, North J, Kaduce T, Buettner G.  Effects of omega-3 fatty acids in endothelial cells.  Birkhauser Verlag, Basel, Switzerland.  1993. 

Spector A, Moore S.  Role of the cerebromicrovascular endothelium and astrocytes in supplying docosahexaenoic acid to the brain.  American Oil Chemist's Society Press.  1993. 

Spector A, Gordon J, Moore S, Kaduce T.  -oxidation of HETEs: a peroxisonal process.  1st International Congress of the International Society for the Study of Fatty Acids and Lipids, Lugano, Switzerland.  1993. 

Murphy S, Kardos S, Moore S, Orgren K, Faraci F.  Astrocyte modulation of cerebral vessel function via prostanoid and non-prostanoid factors.  Society for Neuroscience Meeting.  1992 October. 

Spector A, Moore S, North L, North J, Kaduce T, Buettner G.  Effects of omega-3 fatty acids in endothelial cells.  Omega-3 Fatty Acids - Metabolism & Biological Effects, Oslo, Norway.  1992 September. 

Spector A, Kaduce T, Gordon J, Moore S, VanRollins M.  Metabolic fate of 12-lipoxygenase products.  International Conference on the Biochemistry of Lipids, France.  1992 September. 

Haddad S, Moore S, Schelper R, Goeken J.  Smooth muscle can comprise the sarcomatous component of gliosarcomas.  J Neuropathol Exp Neurol.  1992 September. 51(5):493-8.
[PubMed]

Haddad S, Moore S, Schelper R, Goeken J.  Vascular smooth muscle hyperplasia underlies the formation of glomeruloid vascular structures of glioblastoma multiforme.  J Neuropathol Exp Neurol.  1992 September. 51(5):488-92.
[PubMed]

Haddad S, Moore S, Menezes A, VanGilder J.  Ganglioglioma: 13 years of experience.  Neurosurgery.  1992 August. 31(2):171-8.
[PubMed]

Moore S.  The role of cerebral endothelium and astrocytes in supplying docosahexaenoic acid (22:6-3) to neurons.  Cerebral Vascular Biology Conference, Duluth, MN.  1992 July. 

Henrich D, Gantz B, Moore S, Schubkegel A.  Undifferentiated small-cell neoplasm of the petrous apex - A case report.  Arch Otolaryngol Head Neck Surg.  1992 July. 118(7):767-70.
[PubMed]

Tonner D, Belding P, Moore S, Schlechte J.  Intracranial dissemination of an ACTH secreting pituitary neoplasm--a case report and review of the literature.  J Endocrinol Invest.  1992 May. 15(5):387-91.
[PubMed]

Xu J, Qu Z, Moore S, Hsu C, Hogan E.  Receptor-linked hydrolysis of phosphoinositides and production of prostacyclin in cerebral endothelial cells.  J Neurochem.  1992 May. 58(5):1930-5.
[PubMed]

Wilke W, Burgart L, Robinson R, Haddad S, Moore S.  H-Ras mutations in astrocytomas: Correlation with other oncogene abnormalities.  International Association of Pathologist's Meeting.  1992 March. 

Burgart L, Robinson R, Haddad S, Moore S.  Proliferating cell nuclear antigen (PCNA) expression in astrocytomas: Correlation with oncogenic abnormalities.  International Association of Pathologist's Meeting.  1992 March. 

Spector A, Moore S.  Role of the cerebromicrovascular endothelium and astrocytes in supplying docosahexaenoic acid to the brain.  Third International Congress on Essential Fatty Acids and Eicosanoids, Adelaide, Australia.  1992 March. 

Hart M, Fabry Z, Love-Homan L, Sadewasser K, Moore S.  Brain microvascular smooth muscle and endothelial cells produce granulocyte macrophage colony-stimulating factor and support colony formation of granulocyte-macrophage-like cells.  Am J Pathol.  1992. 141:421-427.

Spector A, Moore S, Gordon E, Gordon J, Kaduce T.  HETEs and endothelial function.  R&L Creative Communications Ltd, Tel Aviv.  1992. 

Simon J, Moore S, Johnson A, Kasson B.  Localization of arginine-vasopressin (AVP) immunoreactivity in vascular compartments and cultured microvascular endothelial and smooth muscle cells.  FASEB J.  1992. 6:A1738.

Gordon D, Biller J, Moore S, Rodnitzky R.  Thalamic ependymoma presenting as recurrent subarachnoid hemorrhage.  J Stroke Cerebrovasc Dis.  1992. 2:106-109.

Mueller D, Moore S, Yuh W, Sato Y.  The MRI spectrum of medulloblastoma.  Clinical Imaging.  1992. 16:250-255.
[PubMed]

Giordano M, Mathur S, Moore S.  Differential metabolism of hydroxyeicosatetraenoic acid isomers by mouse cerebromicrovascular endothelium.  J Neurochem.  1992 January. 58(1):374-82.
[PubMed]

Moore S, Giordano M, Kim H, Salem N, Spector A.  Brain microvessel 12-hydroxyeicosatetraenoic acid is the (S) enantiomer and is lipoxygenase derived.  J Neurochem.  1991 September. 57(3):922-9.
[PubMed]

Moore S, Yoder E, Murphy S, Dutton G, Spector A.  Astrocytes, not neurons, produce docosahexaenoic acid (22:6-3) and arachidonic acid (20:4-6).  Meeting on Neurobiology of Essential Fatty Acids, a satellite meeting of the 13th Biennial Meeting of the International Society for Neurochemistry.  1991 July. 

Moore S, Giordano M, Kim H, Salem Jr N, Spector A.  Brain microvessel 12-hydroxyeicosatetraenoic acid is the (S) enantiomer and is lipoxygenase-derived.  13th Biennial Meeting of the International Society for Neurochemistry.  1991 July. 

Yorek M, Stefani M, Moore S.  Acute and chronic exposure of mouse cerebral microvessel endothelial cells to increased concentrations of glucose and galactose: effect on myo-inositol metabolism, PGE2 synthesis, and Na+/K(+)-ATPase transport activity.  Metabolism: clinical and experimental.  1991 April. 40(4):347-58.
[PubMed]

Burgart L, Robinson R, Haddad S, Moore S.  Oncogene abnormalities in astrocytomas: EGF-R gene alone appears to be more frequently amplified and rearranged compared with other protooncogenes.  Modern Pathology.  1991 March. 4(2):183-6.
[PubMed]

Moore S, Yoder E, Murphy S, Dutton G, Spector A.  Astrocytes, not neurons, produce docosahexaenoic acid (22:6 omega-3) and arachidonic acid (20:4 omega-6).  J Neurochem.  1991 February. 56(2):518-24.
[PubMed]

Moore S, Giordano M, Kim H, Salem Jr N, Spector A.  Brain microvessel 12-hydroxyeicosatetraenoic acid is the (S) enantiomer and is lipoxygenase-derived.  J Neurochem.  1991. 57:S64.

Spector A, Moore S.  Effects of polyunsaturated fatty acids in endothelial cells.  Plenum Publishing Corp, New York NY.  1991. 

Burgart L, Robinson R, Haddad S, Moore S.  Oncogene abnormalities in astrocytomas: EGF-R gene alone appears to be more frequently amplified and rearranged compared to other protooncogenes.  International Association of Pathologists Meeting.  1991. 

Haddad S, Moore S, Goeken J, Schelper R.  Smooth muscle cells can comprise the sarcomatous element of gliosarcomas.  J Neuropathol Exp Neurol.  1991. 50:291.

Mueller D, Moore S, Yuh W, Sato Y.  The MRI spectrum of medulloblastoma.  29th Annual Meeting of the American Society of Neuroradiology.  1991. 

Yuh W, Turk J, Mayr N, Moore S.  Unusual growth and spread of pituitary adenoma: MR and CT findings in four cases.  29th Annual Meeting of the American Society of Neuroradiology.  1991. 

Haddad S, Menezes A, Vangilder J, Moore S.  Ganglioglioma: a 13 year review.  Pediatric Section of the American Association of Neurological Surgeons.  1990 December. 

Giordano M, Moore S.  Prostacyclin synthetase inhibition by metyrapone in cerebromicrovascular endothelium.  American Heart Association, 63rd Scientific Sessions.  1990 November. 

Giordano M, Moore S.  Metabolism of hydroxyeicosatetraenoic acids (HETES) by mouse brain endothelium.  Society for Neuroscience Meeting.  1990 October. 

Fabry Z, Waldschmidt T, Van Dyk L, Moore S, Hart M.  Activation of CD4+ lymphocytes by syngeneic brain microvascular smooth muscle cells.  J Immunol.  1990 August. 145(4):1099-104.
[PubMed]

Dyken M, Biller J, Yuh W, Fincham R, Moore S, Justin E.  Carotid-cavernous sinus thrombosis caused by Aspergillus fumigatus: magnetic resonance imaging with pathologic correlation--a case report.  Angiology.  1990 August. 41(8):652-7.
[PubMed]

Moore S, Yoder E, Spector A.  Role of the blood-brain barrier in the formation of long-chain omega-3 and omega-6 fatty acids from essential fatty acid precursors.  J Neurochem.  1990 August. 55(2):391-402.
[PubMed]

Sahagun G, Moore S, Hart M.  Permeability of neutral vs anionic dextrans in cultured brain microvascular endothelium.  Am J Physiol.  1990 July. 259(1 Pt 2):H162-6.
[PubMed]

Fabry Z, Waldschmidt T, Moore S, Hart M.  Antigen presentation by brain microvessel smooth muscle and endothelium.  J Neuroimmunol.  1990 June. 28(1):63-71.
[PubMed]

Moore S.  Brain microvessel 12-HETE is lipoxygenase-derived.  Annual Meeting of FASEB.  1990 April. 

Moore S, Yoder L, Murphy S, Spector A.  Astrocytes, not neurons, produce 22:6-3 in the brain.  American Society for Neurochemistry Meeting.  1990 March. 

Moore S.  Brain microvessel 12-HETE is lipoxygenase-derived.  FASEB J.  1990. 4:A1098.

Haddad S, Robinson R, Moore S.  DNA flow cytometry is a predictor of survival in astrocytomas.  J Neuropathol Exp Neurol.  1990. 49:321.

Laszewski M, Moore S.  Occult invasive pituitary adenoma predisposing to fatal bacterial meningitis.  Clin Neuropathol.  1990. 9:101-105.

Ou Z, Xu J, Moore S, Hsu C, Hogan E.  Receptor agonists induced-phosphoinositide (PI) turnover in cultured endothelial cells (ECs) of murine brain.  FASEB J.  1990. 4:A1116.

Loes D, Ryals T, Moore S, Yuh W.  Recurrent pituitary adenoma presenting as a posterior fossa mass.  American Society for Neuroradiology.  1990. 

VanRybroek J, Moore S.  Sudden death from bilateral choroid plexus vascular malformation hemorrhage - A case report.  Clin Neuropathol.  1990. 9:39-45.
[PubMed]

Yerram N, Moore S, Spector A.  Eicosapentaenoic acid metabolism in brain microvessel endothelium: effect on prostaglandin formation.  J Lipid Res.  1989 November. 30(11):1747-57.
[PubMed]

Moore S, Figard P, Spector A, Hart M.  Brain microvessels produce 12-hydroxyeicosatetraenoic acid.  J Neurochem.  1989 August. 53(2):376-82.
[PubMed]

Moore S, Prokuski L, Flugum L, Hart M.  Prostaglandin I2 and E2 production by cultured cerebromicrovascular smooth muscle is dependent upon serum.  65th Annual Meeting of the American Association of Neuropathologists.  1989 June. 

Sahagun G, Moore S, Fabry Z, Schelper R, Hart M.  Purification of murine endothelial cell cultures by flow cytometry using fluorescein-labeled griffonia simplicifolia agglutinin.  Am J Pathol.  1989 June. 134(6):1227-32.
[PubMed]

Moore S, Yoder E, Spector A.  Cerebral endothelia provide essential fatty acids for the brain.  Annual Meeting of the American Society for Neurochemistry Meeting.  1989 March. 

Moore S, Yoder E, Spector A.  Human microvascular endothelium produce arachidonate (20:4-6), eicosapentaenoate (20:5-3), and docosahexaenoate (22:6-3) from essential fatty acid precursors.  Annual Meeting of FASEB.  1989 March. 

Xu J, Chao J, Moore S, Hogan E, Hsu C.  Effects of polymorphonuclear cells (PMNs) on the formation of eicosanoids and kinins by a murine endothelial cell (CEC) line.  Society for Neuroscience Abstracts.  1989. 

Moore S, Figard P, Spector A, Hart M.  Eicosanoid production by isolated cerebral microvessels and cultured cerebral endothelium.  Ann NY Acad Sci.  1989. 559:471-473.

Moore S, Figard P, Spector A, Hart M.  Eicosanoid production by isolated cerebral microvessels and cultured cerebral endothelium.  The New York Academy of Sciences, New York NY.  1989. 

Moore S, Yoder E, Spector A.  Human microvascular endothelium produce arachidonate (20:4-6), eicosapentaenoate (20:5-3), and docosahexaenoate (22:6-3) from essential fatty acid precursors.  FASEB J.  1989. 3:A705.

Sandor M, Fabry Z, Moore S, Schelper R, Hart M, Lynch R.  IgG Fc receptor expression on cell lines established from murine brain.  FASEB J.  1989. 3:A1328.

Moore S, Prokuski L, Flugum L, Hart M.  Prostaglandin I2 and E2 production by cultured cerebromicrovascular smooth muscle is dependent upon serum.  J Neuropathol Exp Neurol.  1989 January. 38:320.

Moore S, Prokuski L, Figard P, Spector A, Hart M.  Murine cerebral microvascular endothelium incorporate and metabolize 12-hydroxyeicosatetraenoic acid.  J Cell Physiol.  1988 October. 137(1):75-85.
[PubMed]

Perlman S, Jacobsen G, Moore S.  Regional localization of virus in the central nervous system of mice persistently infected with murine coronavirus JHM.  Virology.  1988 October. 166(2):328-38.
[PubMed]

Moore S, Flugum L, Spector A.  Cerebromicrovascular endothelium produce 12-HETE.  5th International Symposium on the Biology of Vascular Endothelial Cells.  1988 July. 

Moore S, Prokuski L, Figard P, Spector A, Hart M.  12-Hydroxyeicosatetraenoic acid (12-HETE) is produced by cerebral microvessels and inhibits prostaglandin production in cerebral endothelium.  Annual Meeting of FASEB.  1988. 

Moore S, Prokuski L, Figard P, Spector A, Hart M.  12-Hydroxyeicosatetraenoic acid (12-HETE) is produced by cerebral microvessels and inhibits prostaglandin production in cerebral endothelium.  FASEB J.  1988. 2:A1522.

Sahagun G, Fabry Z, Schelper R, Moore S, Hart M.  Characterization and purification of endothelial cells in culture by flow cytometry using a fluorescent-labeled Griffonia simplicifolia agglutinin-I (GSA) lectin.  FASEB J.  1988. 2:A933.

Sahagun G, Moore S, Hart M.  Charge and size effects on transport of sulfated and non-sulfated macromolecules across cultured endothelial monolayers.  Clin Res.  1988. 36.

Moore S, Spector A, Hart M.  Eicosanoid metabolism in cerebromicrovascular endothelium.  Am J Physiol.  1988. 254:C37-C44.
[PubMed]

Moore S, Spector A, Gordon J.  Hydroxyeicosatetraenoic acids (HETEs).  Prog Lipid Res.  1988. 27:271-323.
[PubMed]

Schelper R, Moore S, Hart M.  True reactive microglia lack muscle-pericyte specific -actin.  J Neuropathol Exp Neurol.  1988. 47:362.

Moore S, Spector A, Hart M.  Cerebral endothelia release prostaglandins in response to thrombin, bradykinin, serotonin and acetylcholine.  Annual Meeting of the Society for Neuroscience.  1987 November. 

Vinters H, Reave S, Costello P, Girvin J, Moore S.  Isolation and culture of cells derived from human cerebral microvessels.  Cell and tissue research.  1987 September. 249(3):657-67.
[PubMed]

Moore S, Spector A, Hart M.  12-hydroxyeicosatetraenoic acid is the major metabolite of arachidonic acid in brain microvessels.  63rd Annual Meeting of the American Association of Neuropathologists.  1987 June. 

Moore S, Spector A, Hart M.  Cerebral endothelia produce prostaglandin I2 and E2 in vitro and release them predominantly from their basal surfaces.  Biology of Cerebral Endothelium Symposium.  1987 June. 

Hart M, Waldschmidt T, Hanley-Hyde J, Moore S, Kemp J, Schelper R.  Brain microvascular smooth muscle expresses class II antigens.  J Immunol.  1987 May. 138(9):2960-3.
[PubMed]

Spencer S, Walker F, Moore S.  Chorea-amyotrophy with chronic hemolytic anemia: a variant of chorea-amyotrophy with acanthocytosis.  Neurology.  1987 April. 37(4):645-9.
[PubMed]

Moore S, Spector A, Hart M.  Cerebral endothelial eicosanoid production in vitro.  71st Annual Meeting of the Federation of American Societies for Experimental Biology.  1987 March. 

Hart M, VanDyk L, Moore S, Shasby D, Cancilla P.  Differential opening of the brain endothelial barrier following neutralization of the endothelial luminal anionic charge in vitro.  J Neuropathol Exp Neurol.  1987 March. 46(2):141-53.
[PubMed]

Biller J, Loftus C, Moore S, Schelper R, Danks K, Cornell S.  Isolated central nervous system angiitis first presenting as spontaneous intracranial hemorrhage.  Neurosurgery.  1987 February. 20(2):310-5.
[PubMed]

Moore S, Spector A, Hart M.  12-hydroxyeicosatetraenoic acid is the major metabolite of arachidonic acid in brain microvessels.  J Neuropathol Exp Neurol.  1987. 46:400.

Moore S, Spector A, Hart M.  Cerebral endothelia produce prostaglandin I2 and E2 in vitro and release them predominantly from their basal surfaces.  Canadian J Neurol Sci.  1987. 14:337.

Moore S, Spector A, Hart M.  Cerebral endothelial eicosanoid production in vitro.  Fed Proc.  1987. 46:355.

Lagreze H, Brooks B, Moore S, Spencer S, Kornguth S, Bridges A, Levine R, Perlman S.  Familial amyotrophy, neuropathy, chorea and dementia with spherocytosis/elliptocytosis: a new syndrome.  Neurol.  1987. 37 (Suppl):139.

Whitters E, Schelper R, Moore S, Hart M.  Lectin and anti-alpha-actin staining to monitor purity of endothelium and vascular muscle culture.  Fed Proc.  1987. 46:1230.

Schelper R, Moore S, Whitters E.  True reactive microglia: non-monocytic, non-pericytic cells of the CNS.  Fed Proc.  1987. 46:1321.

Hart M, Moore S, Van Dyk L, Roberts R.  Are tight junctions necessary for blood-brain barrier function?.  1986 September. 

Barloon T, Moore S, Mitros F.  A case of stenotic obstruction of the jejunum secondary to slow-release potassium.  Am J Gastroenterol.  1986 March. 81(3):192-4.
[PubMed]

Smoker W, Biller J, Moore S, Beck D, Hart M.  Intradural spinal teratoma: report of a case and review of the literture.  Am J Neuroradiol.  1986. 7(905-910).
[PubMed]

Hart M, Tassell S, Sadewasser K, Schelper R, Moore S.  Autoimmune vasculitis resulting from in vitro immunization of lymphocytes to smooth muscle.  The American journal of pathology.  1985 June. 119(3):448-55.
[PubMed]

Hart M, Sadewasser K, Tassell S, Waldschmidt T, Schelper R, Moore S.  Autoimmune vasculitis, a model.  Fed Proc.  1985. 44:957.

Moore S, Bohlen H, Miller B, Evan A.  Cellular and vessel wall morphology of cerebral cortical arterioles after short-term diabetes in adult rats.  Blood Vessels.  1985. 22:265-277.

Moore S, Roberts R, Van Dyk L, Hart M.  Cerebral transendothelial electrical resistance in vitro.  61st Annual Meeting of the American Association of Neuropathologists. .  1985. 

Moore S, Roberts R, Van Dyk L, Hart M.  Cerebral transendothelial electrical resistance in vitro.  J Neuropath Exp Neurol.  1985. 44:340.

Moore S, Schelper R, Hart M, Robinson R, Whitters E.  Glomeruloid hyperplasia in glioblastoma: origin from smooth muscle cells.  62nd Annual Meeting of the American Association of Neuropathologists. .  1985. 

Moore S, Schelper R, Hart M, Robinson R, Whitters E.  Glomeruloid hyperplasia in glioblastoma: origin from smooth muscle cells.  J Neuropathol Exp Neurol.  1985. 45:327.

Vinters H, Reave S, Costello P, Girvin J, Moore S.  Isolation and culture of cells derived from human cerebral microvessels.  J Neuropathol Exp Neurol.  1985. 44:338.

Schelper R, Hart M, Moore S, Whitters E.  True reactive microglia produced by injury to central neuronal processes.  J Neuropathol Exp Neurol.  1985. 45:345.

Moore S, Strauch A, Yoder E, Rubenstein P, Hart M.  Cerebral microvascular smooth muscle in tissue culture.  In vitro.  1984 June. 20(6):512-20.
[PubMed]

Beck D, Vinters H, Moore S, Hart M, Henn F, Cancilla P.  Demonstration of adenosine receptors on mouse cerebral smooth muscle membranes.  Stroke.  1984. 15(725-727).
[PubMed]

Robinson R, Moore S, Hart M.  Growth control of cerebral microvessel derived smooth muscle cells.  J Cellular Biochem Suppl.  1984. 8A:255.

Beck D, Vinters H, Moore S, Hart M, Cancilla P.  Uptake of adenosine by cultured cerebral vascular smooth muscle cells.  Journal of neurochemistry.  1983 October. 41(4):939-41.
[PubMed]

Westfall S, Felten D, Mandelbaum J, Moore S, Peterson R.  Degenerative neuropathy in insulin-treated diabetic rats.  Journal of the neurological sciences.  1983 September. 61(1):93-107.
[PubMed]

Moore S, Miller B, Bohlen H, Evan A.  Scanning and transmission electron microscopic study of cerebral vascular smooth muscle in normal and in diabetic rats.  67th Annual Meeting of the Federation of American Societies for Experimental Biology.  1983 April. 

Moore S, Miller B, Bohlen H, Evan A.  Scanning and transmission electron microscopic study of cerebral vascular smooth muscle in normal and in diabetic rats.  67th Annual Meeting of the Federation of American Societies for Experimental Biology.  1983 April. 

Moore S, Yoder E, Strauch A, Rubenstein P, Hart M.  Isolation and characterization of mouse cerebral vascular smooth muscle in tissue culture.  Eighth International Joint Conference on Stroke and Cerebral Circulation.  1983 February. 

Beck D, Vinters H, Hart M, Henn F, Moore S, Cancilla P.  Adenosine and cerebral smooth muscle: uptake and binding.  Fed Proc.  1983. 42:484.

Moore S, Yoder E, Strauch A, Rubenstein P, Hart M.  Isolation and characterization of mouse cerebral vascular smooth muscle in tissue culture.  Stroke.  1983. 14:131.

Moore S, Miller B, Bohlen H, Evan A.  Scanning and transmission electron microscopic study of cerebral vascular smooth muscle in normal and in diabetic rats.  Fed Proc.  1983. 42:485.

Rhodes G, Holland M, Wiesler D, Novotný M, Moore S, Peterson R, Felten D.  Excretion of urinary volatile metabolites in response to alloxan induced diabetes of short duration in rats.  Journal of chromatography.  1982 March. 228:33-42.
[PubMed]

Moore S, Peterson R, Felten D, O'Connor B.  Ultrastructural axonal pathology in experimentally diabetic and aging control rats.  Brain research bulletin.  1982 March. 8(3):317-23.
[PubMed]

Rhodes G, Holland M, Wiesler D, Novotny M, Moore S, Peterson R, Felten D.  Structural relationships between the endogenous volatile urinary metabolites of experimentally diabetic rats and certain neurotoxins (l).  Experientia.  1982 January. 38(1):75-7.
[PubMed]

Baughman S, Felten S, Lee W, Moore S, O'Connor B, Peterson R.  The effect of diabetes on leucine and fucose incorporation into PNS myelin proteins.  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme.  1981 June. 13(6):331-5.
[PubMed]

Moore S, Peterson R, Felten D, O'Connor B.  Glycogen accumulation in tibial nerves of experimentally diabetic and aging control rats.  J Neurol Sci.  1981. 52:289-303.
[PubMed]

Moore S, Peterson R, Felten D, Cartwright T, O'Connor B.  Reduced sensory and motor conduction velocity in 25-week-old diabetic [C57BL/Ks (db/db)] mice.  Experimental neurology.  1980 December. 70(3):548-55.
[PubMed]

Moore S, Peterson R, Felten D, O'Connor B.  A quantitative comparison of motor and sensory conduction velocities in short- and long-term streptozotocin- and alloxan-diabetic rats.  Journal of the neurological sciences.  1980 October. 48(1):133-52.
[PubMed]

Moore S, O'Connor B, Felten D, Peterson R.  Ultrastructural changes in tibial nerves of two month streptozotocin and alloxan diabetic rats.  Am. Assoc. of Neuropathologists Meeting.  1980 June. 

Moore S, Cartwright T, O'Connor B, Felten D, Peterson R.  Motor and sensory conduction velocity study in the genetically diabetic (db/db) mouse.  Midwest Student Medical Research Forum.  1980 March. 

Moore S, Cartwright T, O'Connor B, Felten D, Peterson R.  Motor and sensory conduction velocity study in the genetically diabetic (db/db) mouse.  Clin Res.  1980. 28:801A.

Cartwright T, Moore S, O'Connor B, Felten D, Peterson R.  Peripheral neuropathy in diabetic (db/db) mice.  Clin Res.  1980. 28:797A.

Smith S, Novotny M, Moore S, Felton D.  Studies of hyperlipidemia in drug-induced diabetic rats by high-performance liquid chromatography.  J Chrom Biomed Appl.  1980. 221:19-26.

Felten S, Baughman S, Lee W, Moore S, Peterson R.  The effect of diabetes on glycoprotein incorporation into PNS myelin.  Trans Amer Soc Neurochem.  1980. 11:215.

Moore S, O'Connor B, Felten D, Peterson R.  Ultrastructural changes in tibial nerves of two month streptozotocin and alloxan diabetic rats.  J Neruopathol Exp Neurol.  1980. 39:377.

Moore S, Peterson R, Felten D, O'Connor B.  Early segmental demyelination in experimental diabetic neuropathy.  Neuroscience Abstracts.  1979 November. 5:515.

Moore S, Peterson R, Felten D, O'Connor B.  Early segmental demyelination in experimental diabetic neuropathy.  Society for Neuroscience Meetings.  1979 November. 

Moore S, O'Connor B, Felten D, Peterson R.  Experimental diabetic neuropathy - (Dealing with preliminary conduction velocity findings).  Diabetes.  1979. 28:415.

Moore S, O'Connor B, Peterson R.  Experimental diabetic neuropathy - (Dealing with preliminary electron microscopic findings).  American Association of Anatomists Meeting.  1979. 

Moore S, O'Connor B, Peterson R.  Experimental diabetic neuropathy - (Dealing with preliminary electron microscopic findings).  Anat Rec.  1979. 193:627.

Date Last Modified: 06/07/2014 - 21:56:23